Evidence map›Paper›PMID 41784365›Full record

ArticleAntimicrobial agents and chemotherapy2026

Daniel C Bailey, Salvador Castañeda-Barba, Katie E Barry, Puthayalai Treerat, Matthew A Crawford, Molly A Hughes, Amy J Mathers

Abstract readCase Reports
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. From Environmental Organism to Nosocomial Threat:Antibiotics (Basel, Switzerland) · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Daniel C BaileyDivision of Infectious Diseases and International Health, Department of Medicine, University of Virginia School of Medicine, Charlottesville, Virginia, USA.ORCID 0000-0003-4126-8700
Salvador Castañeda-BarbaDivision of Infectious Diseases and International Health, Department of Medicine, University of Virginia School of Medicine, Charlottesville, Virginia, USA.ORCID 0009-0005-7444-2658
Katie E BarryDivision of Infectious Diseases and International Health, Department of Medicine, University of Virginia School of Medicine, Charlottesville, Virginia, USA.
Puthayalai TreeratDivision of Infectious Diseases and International Health, Department of Medicine, University of Virginia School of Medicine, Charlottesville, Virginia, USA.ORCID 0000-0003-0028-398X
Matthew A CrawfordDivision of Infectious Diseases and International Health, Department of Medicine, University of Virginia School of Medicine, Charlottesville, Virginia, USA.ORCID 0000-0003-0404-0061
Molly A HughesDivision of Infectious Diseases and International Health, Department of Medicine, University of Virginia School of Medicine, Charlottesville, Virginia, USA.ORCID 0000-0003-0360-5200
Amy J MathersDivision of Infectious Diseases and International Health, Department of Medicine, University of Virginia School of Medicine, Charlottesville, Virginia, USA.ORCID 0000-0002-3533-6351

Funding

National Institute of Allergy and Infectious Diseases AI007046National Institute of Allergy and Infectious Diseases AI150941
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-Bacterial Agentsbeta-Lactamase Inhibitorsbeta-LactamasesSerratia InfectionsSerratia marcescensAzabicyclo CompoundsBacterial Proteinsbeta-LactamsBoronic AcidsCefiderocolCeftazidimeDrug CombinationsDrug Resistance, Multiple, BacterialHumansKlebsiella pneumoniaeMeropenemAnti-Bacterial Agentsavibactam, ceftazidime drug combinationAzabicyclo CompoundsBacterial Proteinsbeta-Lactamase Inhibitorsbeta-Lactamasesbeta-LactamsBoronic AcidsCefiderocolCeftazidimeDrug CombinationsMeropenemThird Generation Cephalosporinsallele variationavibactam resistancecarbapenem resistancecarbapenem-resistant Enterobacteralesceftazidime-avibactamKlebsiella pneumoniae carbapenemaseKPC-44multidrug resistancerelebactam resistanceSerratia marcescensvaborbactam resistance

Identifiers

PMID41784365
PMCPMC13041313

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.